Anders Bjartell (@bjartell) 's Twitter Profile
Anders Bjartell

@bjartell

ID: 923905517726126080

calendar_today27-10-2017 13:33:35

272 Tweet

268 Followers

91 Following

Sabine D. Brookman-May (@brookmans76) 's Twitter Profile Photo

On top of great lectures and abstracts presented at #EAU24 + the chance to kick off and work on #urology #research projects, it was simply good to meet colleagues and friends in Paris

On top of great lectures and abstracts presented at #EAU24 + the chance to kick off and work on #urology #research projects, it was simply good to meet colleagues and friends in Paris
Stacy Loeb, MD (@loebstacy) 's Twitter Profile Photo

🌟 And the winner is…. Androgen receptor pathway inhibitors (ARPI) for referring to the drugs abiraterone, apalutamide, enzalutamide & darolutamide. Standardizing terminology can reduce confusion from all different terms used in the literature #APCCC24

🌟 And the winner is…. Androgen receptor pathway inhibitors (ARPI) for referring to the drugs abiraterone, apalutamide, enzalutamide & darolutamide. Standardizing terminology can reduce confusion from all different terms used in the literature #APCCC24
Sigrid Carlsson (@sigridcarlsson) 's Twitter Profile Photo

Inspiring conference with brilliant minds dedicated to advancing prostate cancer research and patient outcomes. Discussing the role of biomarkers, genetics and MRI in prostate cancer screening. Thank you OncLive.com and David Crawford, MD for organizing! ✨ Simpa Salami Brian Helfand MD, PhD

Inspiring conference with brilliant minds dedicated to advancing prostate cancer research and patient outcomes. Discussing the role of biomarkers, genetics and MRI in prostate cancer screening. Thank you <a href="/OncLive/">OncLive.com</a> and <a href="/DavidCrawfordMD/">David Crawford, MD</a> for organizing! ✨ <a href="/samsimsal/">Simpa Salami</a> <a href="/prost8helf/">Brian Helfand MD, PhD</a>
high5md (@high5md) 's Twitter Profile Photo

📺 #High5oncologyTV presents in-depth #RenalCellCarcinoma discussions from #ASCO24. Learn from leading experts about the newest treatments and research.high5oncology.tv/meeting-covera… Free access for HCPs. Sign up today! #CancerCare #RCC joaquim bellmunt Anders Bjartell Simon C

📺 #High5oncologyTV presents in-depth #RenalCellCarcinoma discussions from #ASCO24. Learn from leading experts about the newest treatments and research.high5oncology.tv/meeting-covera… Free access for HCPs. Sign up today! #CancerCare #RCC

<a href="/OncoBellmunt/">joaquim bellmunt</a> <a href="/bjartell/">Anders Bjartell</a> <a href="/scserendipity1/">Simon C</a>
Tyler Seibert MD PhD (@tylersbrt) 's Twitter Profile Photo

💔😞 RIP, my friend Felix Feng Please consider donating to the American Cancer Society ASTRO Felix Feng MD Clinician Scientist Grant Award. Let his incredible legacy live on. donate.cancer.org/g/tjjfqwdnrxrl…

Carissa Chu (@cchumd) 's Twitter Profile Photo

Today we lost a dear friend and mentor. A brilliant mind and a generational talent with fire in his belly til the end. You will remain an eternal presence in my career and countless others in this community you have built. We mourn now, and then keep building for Felix Feng.

Today we lost a dear friend and mentor. A brilliant mind and a generational talent with fire in his belly til the end. You will remain an eternal presence in my career and countless others in this community you have built. We mourn now, and then keep building for <a href="/felixfengmd/">Felix Feng</a>.
Nick James also on @Prof-Nick-James.bsky.social (@prof_nick_james) 's Twitter Profile Photo

So sad to hear about Felix Feng passing away. A true giant of oncology but also the loveliest man you could ever hope to meet. A joy both to work with and to be with. His premature death a massive loss to humanity and a stark reminder why we do what we do. Rest in Peace 😢

So sad to hear about <a href="/felixfengmd/">Felix Feng</a> passing away. A true giant of oncology but also the loveliest man you could ever hope to meet. A joy both to work with and to be with. His premature death a massive loss to humanity and a stark reminder why we do what we do. Rest in Peace 😢
Stacy Loeb, MD (@loebstacy) 's Twitter Profile Photo

Exciting to see the increasing applications of genetics and genomics for precision risk stratification & management of #prostatecancer - we are only at the beginning! -Nice talk by Attard #APCCCDiagnostics25 OncoAlert

Exciting to see the increasing applications of genetics and genomics for precision risk stratification &amp; management of #prostatecancer - we are only at the beginning! -Nice talk by Attard  #APCCCDiagnostics25 <a href="/OncoAlert/">OncoAlert</a>
Veeru Kasi (@veerukasi) 's Twitter Profile Photo

Delighted to be speaking here in #Lugano for the #APCCC. Really beautiful location, great talks. Looks like a win 🏆 for MRI in the diagnosis of patients with suspected prostate cancer. BURST Urology European Society of Residents in Urology BAUS prof. Stefano Fanti Ken Herrmann Stacy Loeb, MD

Delighted to be speaking here in #Lugano for the #APCCC. Really beautiful location, great talks. Looks like a win 🏆 for MRI in the diagnosis of patients with suspected prostate cancer. <a href="/BURSTurology/">BURST Urology</a> <a href="/ESRUrology/">European Society of Residents in Urology</a> <a href="/BAUSurology/">BAUS</a> <a href="/stefanofanti4/">prof. Stefano Fanti</a> <a href="/ProfKHerrmann/">Ken Herrmann</a> <a href="/LoebStacy/">Stacy Loeb, MD</a>
Matt Cooperberg (@dr_coops) 's Twitter Profile Photo

Presenting the sorely outdated NCCN risk groups Daniel E Spratt #APCCCdiagnostics. Are they better than nothing? Sure. Can we do (much) better, for free, in 2025? Absolutely!

Presenting the sorely outdated NCCN risk groups <a href="/DrSpratticus/">Daniel E Spratt</a> #APCCCdiagnostics. Are they better than nothing? Sure. 

Can we do (much) better, for free, in 2025? Absolutely!
Stacy Loeb, MD (@loebstacy) 's Twitter Profile Photo

Nice talk on the limitations of conventional risk classifications used in #prostatecancer and using Decipher to improve risk stratification & treatment planning -Daniel E Spratt #APCCCDiagnostics25 OncoAlert

Nice talk on the limitations of conventional risk classifications used in #prostatecancer and using Decipher to improve risk stratification &amp; treatment planning -<a href="/DrSpratticus/">Daniel E Spratt</a> #APCCCDiagnostics25 <a href="/OncoAlert/">OncoAlert</a>
Stacy Loeb, MD (@loebstacy) 's Twitter Profile Photo

Voting results from the panel about use of genomic classifier testing in patients with localized prostate cancer and in patients with adverse prostatectomy pathology Derya Tilki, MD #APCCCDiagnostics25 OncoAlert

Voting results from the panel about use of genomic classifier testing in patients with localized prostate cancer and in patients with adverse prostatectomy pathology <a href="/Tilki_De/">Derya Tilki, MD</a> #APCCCDiagnostics25 <a href="/OncoAlert/">OncoAlert</a>
OncoAlert (@oncoalert) 's Twitter Profile Photo

A GREAT DAY ONE #APCCCDiagnostics25 in Lugano🇨🇭 Here is Event Co-Organizer prof. Stefano Fanti 🇮🇹 with a quick wrap up of DAY ONE and a Warm Invite to Join Us Tomorrow for DAY TWO of Advanced Prostate Cancer Consensus Conference Diagnostics Scientific Committee Ken Herrmann 🇩🇪 prof. Stefano Fanti 🇮🇹 silke gillessen

Bárbara Melão, MD, PhD (@bavilima) 's Twitter Profile Photo

Prof Anders Bjartell was honored with the Life Time Achievement Award at #EAU25 for his outstanding contributions to urology. 👏👏👏👏 A leading expert in #ProstateCancer, his research has advanced diagnostics and treatment. His legacy in science, mentorship, and innovation continues

Prof <a href="/bjartell/">Anders Bjartell</a> was honored with the Life Time Achievement Award at #EAU25 for his outstanding contributions to urology. 
👏👏👏👏
A leading expert in #ProstateCancer, his research has advanced diagnostics and treatment. His legacy in science, mentorship, and innovation continues